12-P | Beneficial Effect of Resveratrol to Inhibit Pathological Myofibroblast Differentiation of Valvular Interstitial Cell in Experimental Heart Valve Model | Ricardo Adrian Nugraha | Received |
15-P | IMMUNE SYSTEM ACTIVATION IN RHEUMATIC HEART DISEASE | Abdul Wajid Khan Faisal | Received |
16-P | IMPROVISED TRICUSPID ANNULOPLASTY DURING LEFT SIDE VALVE SURGERY CAUSED BY RHEUMATIC HEART DISEASE. | Fekede agwar | Received |
17-P | Doctors with borders: the impact of international travel bans on Timorese citizens awaiting cardiac intervention | Elizabeth Paratz | Received |
18-P | Taking the pulse of Timor-Leste€s cardiac needs: a ten-year descriptive time-trend analysis | Elizabeth Paratz | Received |
19-P | Adult and paediatric cardiac intervention in Timor-Leste: disease burden, demographics and clinical outcomes | Elizabeth Paratz | Received |
20-P | Telemedicine to Timor-Leste: implementing an international cardiac telehealth service during population dislocation, floods and COVID-19 | Elizabeth Paratz | Received |
22-P | Echocardiographic profile of children with Rheumatic Heart Disease at Tertiary Cardiac Center of Nepal | Subhash Shah | Received |
34-P | A snowball approach for screening of asymptomatic Rheumatic Heart Disease among school age children in Ethiopia: A comparative cross-sectional study | Demeke Mekonnen Mengistie | Received |
36-P | MitraClip versus Pascal in transcatheter mitral valve repair (TMVR) and the most valuable outcomes following surgery: A systematic review meta-analysis of 1398 patients. | Mohamed Gbreel | Received |
37-P | Follow-up echocardiographic changes in children and youth aged less than 25 years with latent rheumatic heart disease: A systematic review and meta-analysis of global data. | Carl Francia | Received |
39-P | RHEUMATIC HEART DISEASE AN ECHO BASED SCREENING: A FOUR -YEAR AUDIT OF SUVA SCHOOL PROGRAM FROM 2018-2021 | Valeria Walesi Natuman | Received |
41-P | FACTORS ASSOCIATED WITH SEVERITY OF RHEUMATIC HEART DISEASE AMONG PATIENTS IN MOI TEACHING AND REFERRAL HOSPITAL, KENYA, 2020 | Nasirumbi Magero | Received |
44-P | MANAGEMENT OF ACQUIRED HEART VALVULOPATHY: CROSS-SECTIONAL STUDY ON 159 CASES IN THE CARDIOLOGY DEPARTMENT OF THE IDRISSA POUYE GENERAL HOSPITAL | Aliou Alassane Ngaide | Received |
45-P | A COMPARISON OF STERNAL PRECAUTIONS V/S MODIFIED STERNAL PRECAUTIONS DURING CARDIAC REHABILITATION OF PATIENTS FOLLOWING MEDIAN STERNOTOMY. A RANDOMISED PILOT CONTROLLED TRIAL | Sridhar Shirodkar | Received |
47-P | Prevention of Rheumatic Heart Diseases in Chongwe District, Zambia | Webby Mwamulela | Received |
48-P | ECHOCARDIOGRAPHIC ASSESSMENT OF MITRAL VALVE BY WILKINS SCORING TO DETERMINE THE OUTCOME OF PERCUTANEOUS MITRAL BALLOON VALVULOPLASTY | Zeeshan Ahmed Kayani | Received |
49-P | Clinical presentation, echocardiographic findings and short term outcomes of children admitted with rheumatic heart disease in a tertiary care hospital in Khartoum €Sudan. | Esraa Almahi | Received |
51-P | IRON DEFICIENCY IN CHRONIC HEART FAILURE PATIENTS AT THE UNIVERSITY TEACHING HOSPITAL IN LUSAKA, ZAMBIA. | Sandra Lungu | Received |
53-P | How much penicillin to prevent streptococcal pharyngitis? | Thel Hla | Received |
54-P | EARLY OUTCOMES OF MITRAL VALVE REPLACEMENT PERFORMED BY RESIDENTS ON HIGH RISK PATIENTS AT A CENTRE SERVING URBAN POOR COMMUNITY. (A SINGLE CENTRE EXPERIENCE) | Alfred Omo | Received |
55-P | RHEUMATIC HEART DISEASE IN SCHOOL ATTENDING NEPALESE CHILDREN: A DESCRIPTIVE ANALYSIS OF THE NATIONAL HEART SCREENING DATABASE | Prakash Raj Regmi | Received |
56-P | TRENDS IN RHEUMATIC HEART DISEASE IN EGYPT (2006-2023): DATA FROM THE NATIONAL RHEUMATIC HEART PREVENTION AND CONTROL PROGRAM | Alaaeldin Elghamrawy | Received |
57-P | A STRATEGIC POLICY OF CAPACITY BUILDING FOR THE DEFINITIVE TREATMENT OF ADVANCED RHEUMATIC AND STRUCTURAL HEART PATHOLOGIES-35 YEARS OF EVIDENCE, IMPACT AND LESSONS LEARNED IN UNDERSERVED NATIONS | Nilas Young | Received |
58-P | Effect of rheumatic process on myocardial performance in patients with mild to moderate rheumatic mitral regurgitation: a strain study | Asim Katbeh | Received |
64-P | Filling the evidence gap to reduce the incidence of skin infections through environmental health initiatives | Stephanie Enkel | Received |
65-P | Putting the P in SToP: Health Promotion and Environmental Health in the See, Treat and Prevent Skin Sores and Scabies Trial | Stephanie Enkel | Received |
70-P | PATTERN OF RHEUMATIC HEART DISEASE AND TREATMENT PRACTICES AMONG LIBYAN ADULT FEMALES AT TERTIARY CENTER VALVE CLINIC (TRIPOLI / LIBYA / 2017-2022); THE PERSISTING BURDEN AND CHALLENGES | Elham Elgdhafi | Received |
72-P | DEVELOPMENT OF A PEPTIDE-BASED VACCINE TO PREVENT RHEUMATIC HEART DISEASE | Michael Good | Received |
76-P | RHEUMATIC HEART DISEASE (RHD) BURDEN IN AUSTRALIA: RESULTS AND LEARNINGS FROM USE OF PERSON-LINKED MULTI-JURISDICTIONAL DATA | Judith Katzenellenbogen | Received |
78-P | A STANDARDZIED COMPETENCY TRAINING PROGRAM TO BUILD CAPACITY OF FRONTLINE HEALTHCARE WORKERS TO CONDUCT ECHOCARDIOGRAPHIC SCREENING FOR RHEUMATIC HEART DISEASE | Scott Wirth | Received |
79-P | HIGH RATES OF MORTALITY IN UGANDA FOLLOWING ACUTE RHEUMATIC FEVER: A COMMUNITY-BASED PROSPECTIVE COHORT STUDY | Scott Wirth | Received |
81-P | Subcutaneous infusion of penicillin (SCIP): Preliminary results of a phase II trial | Julie Bennett | Received |
82-P | School and clinical-based experimentation to ascertain Streptococcus pyogenes (Strep A) transmission | Stephanie Enkel | Received |
83-P | HOUSEHOLD TRANSMISSION OF STREPTOCOCCUS PYOGENES (STREP A): A REVIEW TO INFORM POTENTIAL ENVIRONMENTAL HEALTH INTERVENTIONS FOR REMOTE LIVING ABORIGINAL COMMUNITIES AT HIGH RISK OF RHEUMATIC FEVER | Stephanie Enkel | Received |
85-P | RAPID MOLECULAR TESTING AIDS TIMELY DIAGNOSIS OF STREP A INFECTION IN NEW ZEALAND CHILDREN WITH ACUTE RHEUMATIC FEVER | Rachel Webb | Received |
86-P | PAROXYSMAL ATRIAL FIBRILLATION WITH HOLTER ECG MONITORING IN PATIENTS WITH SEVERE RHEUMATIC MITRAL STENOSIS IN SINUS RHYTHM AT TIKUR ANBESSA SPECIALIZED HOSPITAL, AAU: PROSPECTIVE CROSS-SECTIONAL STUDY | Demu Mideksa | Received |
87-P | POST-OPERATIVE OUTCOMES IN CRITICALLY ILL RHEUMATIC HEART DISEASE PATIENTS AT THE SALAM CENTRE FOR CARDIAC SURGERY KHARTOUM (SUDAN): A 5-YEAR RETROSPECTIVE ANALYSIS (2017-2022) | Naomi Kebba | Received |
88-P | RHEUMATIC MITRAL REPAIR IN NEPAL: EARLY EXPERIENCE | Rabindra Timala | Received |
91-P | PREVENTING A FUTURE CRISIS: ADDRESSING RHEUMATIC HEART DISEASE IN SCHOOL STUDENTS IN NOAKHALI DISTRICT, BANGLADESH | Shamim Hayder Talukder | Received |
92-P | VALVE SURGERY IN THE FIGHT AGAINST RHEUMATIC HEART DISEASE (RHD) IN NIGERIA: IS VICTORY IN SIGHT? | Ndubueze Ezemba | Received |
93-P | IMPLEMENTATION OF RHD SCREENING PROGRAMS INVOLVING NONEXPERTS: REALIST INITIAL PROGRAM THEORIES | Benjamin Jones | Received |
94-P | DEVELOPING A STRATEGY FOR POSTOPERATIVE TISSUE VALVE ADVOCACY IN A LOW-RESOURCE SETTING | Julie Carragher | Received |
96-P | AUTOMATED TWO-WAY MESSAGING INTERVENTION TO SUPPORT SECONDARY PROPHYLAXIS ADHERENCE IN RHEUMATIC HEART DISEASE | ndate fall | Received |
97-P | MODES OF TRANSMISSION AND ATTACK RATES OF GROUP A STREPTOCOCCAL INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS | Dr Dylan Barth | Received |
99-P | MATERNAL AND FETAL OUTCOMES OF PER CUTANEOUS BALLOON MITRAL VALVULOPLASTY €IN RHEUMATIC HEART DISEASE(PBMV) DURING PREGNANCY | Hetan Shah | Received |
103-P | THE NEED FOR A ROBUST INFLAMMATORY RESPONSE TO DRIVE CARDIAC DAMAGE IN GAS M PROTEIN INDUCED RAT MODEL OF AUTOIMMUNE VALVULITIS | Natkunam Ketheesan | Received |
106-P | Whole genome sequencing (WGS) to determine the resistome and virulome of GAS to improve management and control of RHD. | Kimona Rampersadh | Received |
107-P | Systematic Review: Understanding the oropharyngeal microbiota in healthy children to inform primary prevention strategies for RHD. | Kimona Rampersadh | Received |
108-P | FROM RESEARCH TO NATIONAL REGISTRY: SCALE OF A NOVEL M-HEALTH APPROACH FOR MANAGING RHD IN UGANDA | Emmy Okello | Received |
109-P | BUILDING THE NEXT GENERATION OF RHD RESEARCH LEADERS IN UGANDA: THE IMPACT D43 TRAINING PROGRAM AT MAKERERE UNIVERSITY | Emmy Okello | Received |
112-P | SCREENING DETECTED SEVERE RHEUMATIC HEART DISEASE IN TIMOR-LESTE - CLINICIANS PERSPECTIVE FROM THE CONTEXT OF LENO BESIK STUDY | Anferida Fernandes | Received |
114-P | Rationale and Design of A Controlled Quasi-Experimental Study Testing The Efficacy of A Rheumatic Heart Disease Education Program in Babati, Tanzania | Jessica Abrams | Received |
116-P | RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE-RELATED KNOWLEDGE, ATTITUDES, PRACTICES, AND HEALTH-SEEKING EXPERIENCES IN FIJI | Jyotishna Mani | Received |
117-P | THE EPIDEMIOLOGY OF RHEUMATIC HEART DISEASE AND ACUTE RHEUMATIC FEVER IN FIJI. | Jyotishna Mani | Received |
119-P | RWANDAN NURSES SAVE LIVES: RHEUMATIC HEART DISEASE | Maria Kidner | Received |
120-P | ANTICOAGULATION MANAGEMENT OF POSTOPERATIVE RHEUMATIC HEART DISEASE PATIENTS IN RWANDA | Nikki Schulick | Received |
122-P | ESTABLISHING DECENTRALIZED RHEUMATIC HEART DISEASE SERVICES IN UGANDA € THE ADD-RHD STUDY: A PRELIMINARY REPORT FROM THE FIELD | Neema Minja | Received |
123-P | STRUCTURED PSYCHOTHERAPY IS BENEFICIAL FOR REDUCING EMOTIONAL DISTRESS IN ADULTS PATIENTS WITH CHRONIC RHEUMATIC VALVULAR HEART DISEASEIN SUB-SAHARAN AFRICA: A CASE REPORT | Adebusola Ogunmodede | Received |
124-P | POPULATION HEALTH IMPACTS OF THE RHEUMATIC FEVER STRATEGY IN AUSTRALIA, 2010-2017 | Ingrid Stacey | Received |
125-P | BUILDING TOWARDS SCALE-UP OF RHEUMATIC HEART DISEASE SERVICES IN UGANDA: THE ADUNU PROGRAM | Doreen Nakagaayi | Received |
126-P | YARNING WITH A REMOTE ABORIGINAL COMMUNITY ABOUT THE FUTURE OF SKIN HEALTH | Rebecca Famlonga | Received |
129-P | ASSESSMENT OF IMMEDIATE POST-OPERATIVE CHANGE IN RIGHT VENTRICULAR FUNCTIONAL PARAMETERS AND ASSOCIATED OPERATIVE CHARACTERISTICS AMONG PATIENTS UNDERGOING MITRAL VALVE REPLACEMENT | Raheela Aamir | Received |
130-P | LACK OF AWARENESS OF SECONDARY RHEUMATIC PREVENTION IN PREOPERATIVE CANDIDATES FOR MITRAL VALVE SURGERY- ALARMING SITUATION | Raheela Aamir | Received |
131-P | OBSTRUCTIVE CORONARY ARTERY DISEASE IN PATIENTS UNDERGOING RHEUMATIC VALVULAR HEART SURGERY | Raheela Aamir | Received |
133-P | A PARTNERSHIP OF CLINICAL EXCELLENCE AND CULTURAL SAFETY | Sara Noonan | Received |
134-P | STopping Acute Rheumatic Fever Infections To Strengthen Health (STARFISH) - What are the most effectiveenvironmental health initiatives to reduce Strep A transmission? | Ainslie Poore | Received |
135-P | Preoperative left ventricular dysfunction is a risk factor for late death in paediatric patients after Rheumatic Heart Disease surgery for isolated aortic valve disease | Hilary Hardefeldt | Received |
136-P | Modelling the epidemiological impact of vaccines against group A Streptococcus: Strengths, challenges, and future directions. | Jeffrey Cannon | Received |
138-P | DECOLONISING RHD: ELEVATING THE VOICES OF FIRST NATIONS PEOPLE IN AUSTRALIA | Vicki Wade | Received |
139-P | Retention in Registry-Based Care for Rheumatic Heart Disease in Northern Uganda | Jafesi Pulle | Received |
140-P | RAPID MOLECULAR POINT-OF-CARE TEST FOR STREP A PHARYNGITIS IN REMOTE-LIVING SCHOOL AGED CHILDREN | Janessa Pickering | Received |
141-P | Partnering with the Community to Design a Sore Throat Treatment Program in Uganda | Joselyn Rwebembera | Received |
142-P | THE GAP BETWEEN KNOWLEDGE AND ACTION: UNDERSTANDING COMMUNITY BEHAVIOUR AROUND MANAGEMENT OF PEDIATRIC SORE THROATS IN UGANDA | Juliet Alepere | Received |
143-P | A HEALTH TECHNOLOGY LANDSCAPE ASSESSMENT FOR A NOVEL M-HEALTH APPROACH FOR MANAGING RHEUMATIC HEART DISEASE: LESSONS FROM THE ACT APPLICATION | Jafesi Pulle | Received |
145-P | THE GAP BETWEEN KNOWLEDGE AND ACTION: UNDERSTANDING FRONTLINE HEALTH CARE PROVIDER MANAGEMENT PRACTICES OF PEDIATRIC SORE THROATS IN UGANDA | Gloria Kaudha | Received |
146-P | Partnerships on the Missing Piece Journey to Prevent Acute Rheumatic Fever | Bernadette Wong | Received |
147-P | INTRAMUSCULAR VERSUS ENTERAL PENICILLIN PROPHYLAXIS TO PREVENT PROGRESSION OF LATENT RHEUMATIC HEART DISEASE (the GOAL-IE TRIAL): A NON-INFERIORITY RANDOMIZED TRIAL PROTOCOL | Joselyn Rwebembera | Received |
148-P | ACUTE RHEUMATIC FEVER PRESENTATIONS IN SOUTH AUCKLAND NEW ZEALAND 2020 - 2022 AND IMPACT OF THE GLOBAL COVID-19 PANDEMIC | Adam Dennison | Received |
149-P | Strep A strains in throat and skin identified in Missing Piece Surveillance | Janessa Pickering | Received |
150-P | HAPPY HEART CLINIC. FROM ZERO TO HERO | Erin Ferguson | Received |
151-P | Methods and preliminary data from HYDRxARF, an open label/proof of concept treatment trial of hydroxychloroquine for acute rheumatic fever. | Rebecca Somerville | Received |
152-P | Surveillance results from the Missing Piece Study | Janessa Pickering | Received |
153-P | Telling the Missing Piece Story: Participatory Action with a Community in the Kimberley | Kassandra Fernando | Received |
154-P | ADDRESSING RHEUMATIC HEART DISEASE IN FIJI THE PACIFIC ISLANDS: A PAEDIATRICIAN€S PERSPECTIVE OF CHALLENGES AND THE WAY FORWARD. | Mary Anne Harihiru Koraai | Received |
155-P | DISSEMINATING THE RESULTS OF THE STOP TRIAL ACROSS NINE REMOTE ABORIGINAL COMMUNITIES IN THE AUSTRALIAN KIMBERLEY | Asha Bowen | Received |
156-P | STOP: A COMMUNITY-ENGAGED APPROACH TO TACKLING THE HIGH BURDEN OF SKIN SORES IN REMOTE-LIVING AUSTRALIAN ABORIGINAL CHILDREN | Asha Bowen | Received |
157-P | A new rapid test approach for the detection of Strep A in the throat and reduction in ARF in remote Australia | Asha Bowen | Received |
158-P | YARNING TO STOP SKIN SORES AND SCABIES: A CULTURALLY-APPROPRIATE METHOD OF EVALUATING A REMOTE CLINICAL TRIAL | Asha Bowen | Received |
159-P | ADHERENCE TO BENZATHINE PENICILLIN G OF ADOLESCENTS WITH RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE IN A TERTIARY HOSPITAL | Ara Noraene Vertudez | Received |
160-P | OUTCOMES FOR SCHOOL CHILDREN WITH SCREENING DETECTED RHEUMATIC HEART DISEASE IN TIMOR-LESTE | Juliana Dos Santos Sarmento | Received |
161-P | First Degree Relative RHD Echocardiographic Screening | Sukafa Matanaicake | Received |
162-P | Prevalence of Rheumatic Heart Disease in Bali, Indonesia: A School-based Echocardiographic Screening | Luh Oliva Saraswati Suastika | Received |
163-P | Assessment of Improvement in Left Atrial Volume Index after Percutaneous Transvenous Mitral Commissurotomy | Asim Ali | Received |
164-P | Molecular Epidemiology of Superficial Streptococcus pyogenes Infections in the SToP Trial, Western Australia | Emma Pearson | Received |
166-P | ECG evolution after hydroxychloroquine treatment in acute rheumatic fever € data from HYDRxARF | Rebecca Somerville | Received |
167-P | Severe RHD from Antenatal Echocardiographic Screening | Sukafa Matanaicake | Received |
168-P | TE MÄ€TAI MANAWA A WHÄ€NAU: Improving access to healthcare and echocardiographic screening for families affected by rheumatic fever in South Auckland, New Zealand | Adam Dennison | Received |
171-P | FIJI ANTENATAL ECHOCARDIOGRAPHY SCREENING (FANS) FOR RHEUMATIC HEART DISEASE BY TRAINED NON-EXPERT HEALTH PERSONNEL. | Mairini Rokovunisei | Received |
173-P | TREATING ADVANCED RHEUMATIC HEART DISEASE: THE FIFTEEN-YEAR EXPERIENCE OF SALAM CENTRE FOR CARDIAC SURGERY (KHARTOUM, SUDAN) | Gina Portella | Received |
174-P | Serum FCN-3 protein as a potential biomarker in assessing Rheumatic Heart Disease | Taariq Salie | Received |
175-P | ACCESS TO HEALTHCARE SERVICES FOR PEOPLE LIVING WITH RHEUMATIC HEART DISEASE (PLWRHD) IN A PANDEMIC ENVIRONMENT IN FIJI: LESSONS FROM A TARGETED COVID-19 VACCINATION DRIVE | Jimaima Kailawadoko | Received |
177-P | Use of Alternative Drugs for Rheumatic Fever Prophylaxis in Place of Injection Benzathine Penicillin | Khalida Soomro | Received |
178-P | Resolution and Reduction of Left Atrial Appendage Thrombus in Rheumatic Mitral Stenosis: A Study on the Effects of Oral Anticoagulation | Khalida Soomro | Received |
180-P | DURABILITY AND SAFETY OF PROSTHETIC HEART VALVES IN PATIENTS WITH RHEUMATIC HEART DISEASE: A RETROSPECTIVE COHORT STUDY | Niamh Stevens | Received |
181-P | BRIDGING THE GAP: USING PATIENT-LED INITIATIVES TO ADDRESS RHEUMATIC HEART DISEASE IN FIJI | Erini Kala | Received |
182-P | INTEGRATING ECHO SCREENING INTO THE SCHOOL HEALTH NURSE VISITS IN PRIMARY SCHOOLS IN FIJI ISLANDS | Ilikena Malo | Received |
183-P | Moorditj Skin Means Moorditj Health: Community-led Research in Western Australia Strengthening Aboriginal Childrens Skin Health | Asha Bowen | Received |
185-P | The burden of atopic dermatitis and bacterial skin infections among urban-living Indigenous children and young people in high-income countries: a systematic review | Asha Bowen | Received |
187-P | Rhythm in Rheumatic Heart Disease Patients: Anticoagulation Strategy and 30 days and 6 months Outcomes | Bashir Ahmed | Received |
188-P | The Echocardiographic Diagnosis Of Rheumatic Heart Disease: A Review of the Performance and Application Of The World Heart Federation Criteria | James Marangou | Received |
190-P | NATURAL HISTORY AND RECOMMENDATIONS FOR SECONDARY PROPHYLAXIS OF LATENT RHEUMATIC HEART DISEASE AFTER INITIAL ECHOCARDIOGRAPHIC NORMALISATION | Joselyn Rwebembera | Received |
191-P | Hindering Factors For Secondary Prophalaxis Among Rural Community in Sindh, Pakistan: A Cross-Sectional Study | Kubra Khaliq | Received |
192-P | DEVELOPMENT OF THE ACTIVE COMMUNITY CASE MANAGEMENT TOOL (ACT) - A DYNAMIC APPLICATION FOR RHEUMATIC HEART DISEASE MANAGEMENT | Sarah de Loizaga | Received |
194-P | CASE MANAGERS AND PEER SUPPORT GROUPS (CAMPS) FOR PROPHYLAXIS ADHERENCE IN RHEUMATIC HEART DISEASE | Sarah de Loizaga | Received |
195-P | HEALTH-RELATED QUALITY OF LIFE AND HEALTHCARE CONSULTATIONS AMONG ADULT PATIENTS BEFORE AND AFTER DIAGNOSIS WITH RHEUMATIC HEART DISEASE IN NAMIBIA | Panduleni Penipawa Shimanda | Received |
197-P | A PROSPECTIVE STUDY ON ADHERENCE TO SECONDARY PROPHYLAXIS FOR RHEUMATIC FEVER USING BENZATHINE PENICILLIN G IN MOZAMBIQUE | Zakir Ossman | Received |
198-P | ABSENCE OF GROUP A STREPTOCOCCUS (GAS) IN CHILDREN WITH SUSPECTED PHARYNGITIS IN A HIGHLY ENDEMIC AREA IN MAPUTO CITY DURING THE HOT SEASON | Ananias Muteto | Received |
199-P | CAN WE MODERNIZE THE DIAGNOSIS OF RHD? RATIONALE AND DESIGN OF THE ARC NETWORK | Andrea Beaton | Received |
200-P | RESULTS OF A NOVEL TRAIN THE TRAINER MODEL FOR SCALING RHD ACTIVE CASE FINDING | Doreen Nakagaayi | Received |
201-P | SUBCUTANEOUS ADMINISTRATION OF BENZATHINE PENICILLIN G HAS FAVOURABLE PHARMACOKINETIC CHARACTERISTICS FOR THE PREVENTION OF RHEUMATIC HEART DISEASE. | Joseph Kado | Received |
202-P | ECHOCARDIOGRAPHY TRAINING AMONG HEALTHCARE PROVIDERS IN RURAL RWANDA | Leslie Kaze | Received |
203-P | SUBCUTANEOUS INFUSIONS OF HIGH-DOSE BENZATHINE PENICILLIN G (SCIP) IS SAFE, TOLERABLE AND POTENTIALLY SUITABLE FOR LESS FREQUENT DOSING FOR RHEUMATIC HEART DISEASE SECONDARY PROPHYLAXIS. | Joseph Kado | Received |
204-P | COMMUNITY AWARENESS ON RHEUMATIC HEART DISEASE TRAINING WORKSHOP IN TANZANIA : A PROSPECTIVE OBSERVATIONAL STUDY | Clement Kabakama | Received |
207-P | RISKS FACTORS ASSOCIATED WITH MECHANICAL VALVES THROMBOSIS: THE EXPERIENCE OF SALAM CENTRE FOR CARDIAC SURGERY | Nicoletta Erba | Received |
212-P | REACHING THE UNREACHED: HOW THE MATER HOSPITAL IN KENYA IS BRIDGING A HUGE GAP IN RHEUMATIC FEVER (RF) AND RHEUMATIC HEART DISEASE (RHD) PREVENTION, DIAGNOSIS AND TREATMENT | Agnes Chitira | Received |
214-P | RHEUMATIC HEART DISEASE IN MOZAMBIQUE: RESULTS OF 21 YEARS OF SURGERY | Carol Nhavoto | Received |
218-P | CLINICAL PROFILE AND INTRA-HOSPITAL OUTCOMES OF ADULTS ADMITTED WITH HEART FAILURE DUE TO CHRONIC RHEUMATIC VALVULAR HEART DISEASE IN ILORIN, NORTH CENTRAL NIGERIA € AN EIGHT YEAR HOSPITAL REGISTRY | James Ayodele Ogunmodede | Received |
221-P | Health care provider-led education to prevent streptococcal infections and the risk of rheumatic heart disease: A Systematic Review | Laylah Ryklief | Received |
222-P | TECHNICAL DESIGN CONSIDERATIONS FOR A WEB RHD REGISTRY APPLICATION FOR USE IN LOW-RESOURCE SETTINGS | Riley Morrison | Received |
223-P | CLINICAL AND ECHOCARDIOGRAPHIC OUTCOMES IN RHEUMATIC HEART DISEASE PATIENTS WITH SUPRA-SYSTEMIC PULMONARY HYPERTENSION: THE EXPERIENCE OF THE SALAM CENTRE FOR CARDIAC SURGERY | Franco Masini | Received |
224-P | Humoral immune responses to Streptococcus pyogenes within a household cohort study in The Gambia. | Alex Keeley | Received |
225-P | MITRAL VALVE SURGICAL STRATEGIES FOR PATIENTS IN HAITI: EXPERIENCES AND OUTCOMES | Owen Robinson | Received |
229-P | MITRACLIP/TRICLIP VERSUS PASCAL IMPLANTATION IN PATIENTS UNDERGOING TRANSCATHETER TRICUSPID VALVE REPLACEMENT (TTVR) FOR TRICUSPID REGURGITATION (TR). WHICH SYSTEM IS PREFERRED? A POOLED META-ANALYSIS OF 2178 PATIENTS | Mohamed Gbreel | Received |
230-P | Pacific communities co-designing and leading interventions to prevent rheumatic fever in Aotearoa New Zealand | Siobhan Tuakoi | Received |
231-P | PREVALENCE AND PREDICTORS OF OUTCOME IN PATIENTS WITH PREDOMINANT RHEUMATIC MITRAL STENOSIS IN EASTERN NEPAL | Sahadeb Prasad Dhungana | Received |
232-P | Predictors of blood transfusion among patients who underwent open-heart surgery due to rheumatic heart disease. | Fekede Agwar | Received |
235-P | Targeted profiling of the oropharyngeal microbiota in patients with severe Rheumatic Heart Disease: a case-control study | Evelyn Ngwa Lumngwena | Received |
237-P | Progress towards ending RHD in Australia | Rosemary Wyber | Received |
238-P | A Comparison of Community Sensitization Approaches to Increase Health Seeking Behavior for Acute Rheumatic Fever in Uganda | Rachel Sarnacki | Received |
240-P | GLUCOCORTICOIDS FOR TREATMENT OF SEVERE RHEUMATIC CARDITIS. IS IT STILL AN OPTION? PRELIMINARY RESULTS | Sheila Aissa | Received |
241-P | PROFILE OF RHEUMATIC HEART DISEASE AT CARDIAC CENTER IN MEDAN CITY, INDONESIA: MORBIDITY AND MORTALITY | Tengku Winda Ardini | Received |
242-P | LEFT ATRIAL STRAIN OF LOW GRADIENT SEVERE MITRAL STENOSIS FOLLOWING BALLOON MITRAL VALVULOPLASTY | Nabila Damaiati | Received |
243-P | Left atrial compliance after following percutaneous mitral balloon valvuloplasty is an independent predictor of long-term cardiovascular events | Isabella Fonseca | Received |
244-P | Health Related Quality of Life of Ugandan Children Following Valve Replacement Surgery for Rheumatic Heart Disease | Mohammed Ahmed Mohammed | Received |
245-P | ASSOCIATION OF LEFT ATRIAL STRAIN CHANGES TO FUNCTIONAL CAPACITY IMPROVEMENT IN MITRAL STENOSIS PATIENTS AFTER BALLOON MITRAL VALVULOPLASTY | Yudhistira Kurnia | Received |
247-P | Insights into the mechanisms of left ventricular dysfunction through assessment of diastolic flow in patients with mitral stenosis using 3D echocardiography | MARIA DO CARMO NUNES | Received |
249-P | RESULTS OF MITRAL VALVE REPAIR IN RHEUMATIC HEART DISEASE IN MOZAMBIQUE | Sheila Aissa | Received |
252-P | ENHANCING TERTIARY CARE AND SURGERY IN NAMIBIA: AN ANALYSIS | Josef Nashilongo | Received |
253-P | MORBIDITY, MORTALITY AND SURVIVORSHIP BIAS IN PREVALENT AND INCIDENCE RHEUMATIC HEART DISEASE: A PROSPECTIVE COHORT STUDY | TULIANA CUA | Received |
257-P | CHANGES IN THE RIGHT VENTRICULAR GLOBAL LONGITUDINAL STRAIN AFTER BALLOON MITRAL VALVULOPLASTY: A COMPARISON BETWEEN HIGH GRADIENT VERSUS LOW GRADIENT VERY SEVERE RHEUMATIC MITRAL STENOSIS | Gusti Ayu Temi Vidianti | Received |
260-P | LATENT RHD IN WEST AFRICA (LATTE study) | Lamin Jaiteh | Received |
265-P | Clinical Characteristics and Outcomes of a Contemporary Cohort with Acute Rheumatic Fever from the Northeast Region of Brazil | Renata Mendoza | Received |
266-P | INVESTIGATING BENZATHINE PENICILLIN PROPHYLAXIS IN RHEUMATIC HEART DISEASE MORTALITY: A VERBAL AUTOSPY STUDY | Treasure Mkaliainga | Received |
267-P | EDUCATIONAL TOOLS FOR ENHANCING RHEUMATIC HEART DISEASE AWARENESS IN UNDERSERVED POPULATIONS | MARIA DO CARMO NUNES | Received |
268-P | A PILOT RHEUMATIC HEART DISEASE SCREENING PROGRAM USING PORTABLE, HANDHELD ECHOCARDIOGRAPHY IN RIVAS, NICARAGUA | Matthew Lawlor | Received |
271-P | CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS OF PATIENTS WHO DEVELOPED ADVERSE EVENTS FOLLOWING BENZATHINE PENICILLIN G INJECTION FOR SECONDARY PROPHYLAXIS OF RHEUMATIC HEART DISEASE: EXPERIENCE FROM A UNIVERSITY HOSPITAL IN ETHIOPIA | Abraha Hailu Weldegerima | Received |
272-P | DEVELOPMENT AND VALIDATION OF MULTIPLEXED ELECTROCHEMILUMINESCENT ASSAYS FOR THE MEASUREMENT OF HUMAN IMMUNOGLOBULING ANTIBODIES TO GROUP A STREP ANTIGENS | Alma Fulurija | Received |
274-P | DEADLY HEART TREK: COMMUNITY-CONSULTATION AND CULTURE DRIVEN CARE INITIATIVES TO ENHANCE RHEUMATIC HEART DISEASE ELIMINATION IN REMOTE & REGIONAL COMMUNITIES IN AUSTRALIA | Georgina Byron | Received |
276-P | Left ventricle myocardial work correlated with functional capacity in severe mitral stenosis patients | Estu Rudiktyo | Received |
277-P | OUTCOMES OF AORTIC AND MITRAL VALVE REPLACEMENT IN PATIENTS WITH RHEUMATIC HEART DISEASE | Sheila Aissa | Received |
278-P | A CASE REPORT: BIOLOGICAL MITRAL VALVE REPLACEMENT IN A 12 YEAR OLD GIRL | Amanda Anyoti | Received |
280-P | Antibiotic prevention and management of laboratory confirmed Strep A skin infections to prevent acute rheumatic fever and rheumatic heart disease: A systematic review | Mark Engel | Received |
281-P | A MUCOSAL VACCINE AGAINST STREPTOCOCCUS PYOGENES: THE POTENTIAL TO PREVENT RHEUMATIC HEART DISEASE | Manisha Pandey | Received |
284-P | LONG-TERM OUTCOMES OF RHEUMATIC AORTIC REGURGITATION AFTER PERCUTANEOUS TRANSMITRAL COMMISSUROTOMY | Marrah Angela Comia | Received |
285-P | RELIABILITY AND AGREEMENT OF ECHOCARDIOGRAPHIC MEASURES OF ANTERIOR MITRAL LEAFLET THICKNESS IN PATIENTS WITH RHEUMATIC MITRAL VALVE DISEASE | Manjit Mahendran | Received |
289-P | STREP A PHARYNGITIS RATES IN CHILDREN LIVING IN URBAN AUSTRALIA EMERGING AFTER THE COVID-19 PANDEMIC | Alma Fulurija | Received |
290-P | HEMODYNAMIC PARAMETERS ASSOCIATED WITH SEVERE RHEUMATIC MITRAL STENOSIS WITH LOW TRANSMITRAL GRADIENT | Satrial Iip | Received |
292-P | The Clinical Profile of Rheumatic Heart Disease at a Tertiary Care Hospital in Indonesia: An Observational Study | Dyah Samti Mayasari | Received |
293-P | CLINICAL PROFILE AND ECHOCARDIOGRAPHY FEATURES OF PATIENTS WITH RHEUMATIC HEART DISEASE: SINGLE-CENTRE RETROSPECTIVE STUDY IN INDONESIA | Nani Damanik | Received |
300-P | IN VITRO MODEL OF VALVULAR FIBROSIS: VALVE INTERSTITIAL CELLS OF ORYCTOLAGUS CUNICULUS INDUCED BY TRANSFORMING GROWTH FACTOR- 1, INTERLEUKIN-1, INTERLEUKIN-6, AND TUMOR NECROSIS FACTOR- | NASTITI IMANA INTANSARI | Received |
301-P | Pattern of Rheumatic Heart Disease among Patients Attending at a Tertiary Care Hospital in Somalia: First Report from Somalia | Mohamed Farah Yusuf Mohamud | Received |
302-P | DIGOXIN OR BETA BLOCKER, WHICH AGENT IS SUPERIOR IN THE TREATMENT OF RHEUMATIC HEART DISEASE (RHD) PATIENTS : A RETROSPECTIVE COMPARATIVE STUDY FROM SINGLE-CENTRE RHD REGISTRY | Fitranti Laitupa | Received |
303-P | IS THERE A LINK BETWEEN SOCIODEMOGRAPHIC FACTORS AND RHEUMATIC HEART DISEASE (RHD) SEVERITY: AN INSIGHT FROM SINGLE-CENTER RHD REGISTRY | Fitranti Laitupa | Received |
304-P | THE DETERMINANT FACTORS OF HEART FAILURE IN RHEUMATIC HEART DISEASE (RHD) : A REPORT FROM SINGLE-CENTER SECONDARY CARE HOSPITAL RHD REGISTRY | Fitranti Laitupa | Received |
306-P | Circulating serum levels of Group A Streptococcal antibodies in RHD | Kélin Engel | Received |
308-P | Mucosal immunization with Group A streptococcal antigens elicits the production of functional systemic and mucosal antibodies in mice | Alex Remmington | Received |
309-P | UNDERSTANDING NATURAL IMMUNITY TO GAS: RATIONALE AND DESIGN OF THE ISPY-LIFE SUBSTUDY TO AFFINITY-PURIFY ANTI-STREPTOCOCCAL ANTIBODIES FROM POOLED ADULT IVIG IN SOUTH AFRICA | Mark Engel | Received |
310-P | CLINICAL CHARACTERISTICS AND OUTCOMES OF CHILDREN WITH RHEUMATIC HEART DISEASE: A GLOBAL RHEUMATIC HEART DISEASE REGISTRY (REMEDY) SUB-ANALYSIS | Liesl Zuhlke | Received |
312-P | RHEUMATIC HEART DISEASE GRANT FUNDING AT THE NATIONAL INSTITUTES OF HEALTH, 2010 TO 2022 | Mary Masterson | Received |
313-P | ASSESSING RESEARCH CHALLENGES AND OPPORTUNITIES FOR RHEUMATIC HEART DISEASE: NATIONAL HEART, LUNG, AND BLOOD INSTITUTE WORKSHOP FINDINGS | Mary Masterson | Received |
314-P | CLINICAL AND SOCIO-DEMOGRAPHIC PROFILES OF RHEUMATIC HEART DISEASE IN TERTIARY HOSPITAL IN EASTERN INDONESIA | Aussie Fitriani Ghaznawie | Received |
315-P | UNRAVELING THE BEAT: RBBB AND THE WILKINS SCORE IN MITRAL STENOSIS PROGRESSION | Eva Nur Lizar | Received |
316-P | CLINICAL PROFILE, TREATMENT AND FOLLOW-UP OF PATIENTS WITH RHEUMATIC MITRAL STENOSIS IN A TERTIARY CENTER IN TANZANIA | Reuben Mutagaywa | Received |
317-P | Progressive deterioration in clinical outcome in RHD (influence of therapeutic interventions) | Susy Kotit | Received |
318-P | EVALUATION OF DIAGNOSTIC SCORE FOR RHEUMATIC HEART DISEASE (DSR) TO ASSESS PROGRESSION OF SUBCLINICAL RHD AT 7 YEARS FOLLOW UP | Dinesh Choudhary | Received |
319-P | DIAGNOSIS OF ACUTE RHEUMATIC FEVER FOR RESEARCH AND SURVEILLANCE: LESSONS FROM LAHORE | Gul Afshan | Received |
321-P | ECHOCARDIOGRAPHY SCREENING FOR DIAGNOSIS OF RHEUMATIC HEART DISEASE BY NURSES: A DIAGNOSTIC ACCURACY STUDY IN NEPAL | Prakash Regmi | Received |
322-P | The Role of Biomarkers in Optimizing The Time of Surgical Intervention in Rheumatic Aortic Stenosis | Mohammad Eltahlawi | Received |
323-P | PRIMORDIAL PREVENTION OF RHD: RESEARCH PRIORITIES FOR ADDRESSING THE SOCIAL DETERMINANTS OF HEALTH | Michael Baker | Received |
326-P | Pericardial effusion, nutritional status, and distance from tertiary care predict all-cause mortality among Malawian children with rheumatic heart disease | Amy Sanyahumbi | Received |
328-P | PERINATAL OUTCOMES FOR AUSTRALIAN WOMEN WITH ACUTE RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE | Charles Viska | Received |
329-P | THE 2023 WORLD HEART FEDERATION GUIDELINES FOR THE ECHOCARDIOGRAPHIC DIAGNOSIS OF RHEUMATIC HEART DISEASE | Joselyn Rwebembera | Received |
330-P | A M-PROTEIN BASED SUPER IMMUNOGEN PROVIDES LONG-TERM IMMUNOGENICITY AND PROTECTION AGAINST GROUP A STREPTOCOCCUS (STREPA) UPPER RESPIRATORY TRACT INFECTIONS | Victoria Ozberk | Received |
2-4 November Abu Dhabi
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|